Roger Jeffs - Apr 3, 2022 Form 4 Insider Report for Liquidia Corp (LQDA)

Role
Chief Executive Officer, Director
Signature
/s/ Roger Jeffs
Stock symbol
LQDA
Transactions as of
Apr 3, 2022
Transactions value $
$0
Form type
4
Date filed
10/4/2022, 04:25 PM
Previous filing
Apr 20, 2022
Next filing
May 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LQDA Common Stock Options Exercise +47.4K +29.67% 207K Oct 3, 2022 Direct F1, F2
holding LQDA Common Stock 46.6K Apr 3, 2022 See footnote F3
holding LQDA Common Stock 1.54M Apr 3, 2022 See footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LQDA Restricted Stock Unit Options Exercise $0 -47.4K -75% $0.00 15.8K Oct 3, 2022 Common Stock 47.4K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 On January 3, 2022, the Reporting Person was granted 63,230 RSUs with 25% vesting quarterly through the first anniversary of the grant date. Of those RSUs, a total of 47,423 have vested through October 3, 2022.
F3 The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.
F4 The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.